Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208 USD | -4.55% | -1.21% | -10.09% |
May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
May. 07 | Madrigal Pharmaceuticals Q1 Loss Widens; Shares Fall Pre-Bell | MT |
Financials (USD)
Sales 2024 * | 82.79M | Sales 2025 * | 362M | Capitalization | 4.43B |
---|---|---|---|---|---|
Net income 2024 * | -573M | Net income 2025 * | -375M | EV / Sales 2024 * | 53.1 x |
Net cash position 2024 * | 35.16M | Net Debt 2025 * | 175M | EV / Sales 2025 * | 12.7 x |
P/E ratio 2024 * |
-7.48
x | P/E ratio 2025 * |
-11.6
x | Employees | 376 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.92% |
Latest transcript on Madrigal Pharmaceuticals, Inc.
1 day | -4.55% | ||
1 week | -1.21% | ||
Current month | +1.97% | ||
1 month | -16.33% | ||
3 months | +21.40% | ||
6 months | +45.11% | ||
Current year | -10.09% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Chiang
FOU | Founder | - | 11-08-31 |
William Sibold
CEO | Chief Executive Officer | - | 23-09-07 |
Rebecca Taub
FOU | Founder | 71 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 78 | 11-08-31 | |
Julian Baker
CHM | Chairman | 57 | 23-06-14 |
Ken Bate
BRD | Director/Board Member | 73 | 16-07-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 208 | -4.55% | 690,496 |
24-05-07 | 218 | -7.48% | 780,739 |
24-05-06 | 235.6 | +2.49% | 423,461 |
24-05-03 | 229.8 | +6.38% | 441,775 |
24-05-02 | 216 | +2.59% | 451,720 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.09% | 4.43B | |
+2.93% | 108B | |
-3.84% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- MDGL Stock